Department of Surgery, Creighton University School of Medicine, Omaha, NE, USA.
Department of Medicine/Clinical Research and Evaluative Sciences, Statistician, Creighton University School of Medicine, Omaha, NE, USA.
Surg Endosc. 2023 May;37(5):4018-4027. doi: 10.1007/s00464-022-09588-x. Epub 2022 Sep 12.
Minimally Invasive esophagectomy for esophageal cancer is associated with less morbidity compared to open approach. Whether robotic-assisted minimally invasive esophagectomy (RAMIE) results in better long-term survival compared with open esophagectomy (OE) and minimally invasive esophagectomy (MIE) is unclear.
We analyzed data from the National Cancer Database (NCDB) for patients with primary esophageal cancers who underwent esophagectomy in 2010-2017. Those with unknown staging, distant metastasis, or diagnosed with another cancer were excluded. Patients were stratified by RAMIE, MIE, and OE operative techniques. The Kaplan-Meier method and associated log-rank test were employed to compare unadjusted survival outcomes by surgical technique, our primary outcome. Multivariable Cox proportional hazards regression model was employed to discern factors independently contributing to survival.
A total of 5170 patients who underwent esophagectomy were included in the analysis; 428 underwent RAMIE, 1417 underwent MIE, and 3325 underwent OE. Overall median survival was 42 months. In comparison to RAMIE, there was an increased risk of death for those that underwent either MIE [Hazard Ratio (HR) = 1.19; 95% Confidence Interval (CI): > 1.00 to 1.41; P < 0.047)] or OE (HR = 1.22; 95% CI: 1.04 to 1.43; P < 0.017). Academic vs community program facility type was associated with decreased risk of death (HR = 0.84; 95% CI: 0.76 to 0.93; P < 0.001). In general, males from areas of lower income with advanced stages of cancer who received neoadjuvant chemotherapy or radiation were at increased risk of death. Factors that were not associated with survival included race and ethnicity, Charlson-Devo Score, type of health insurance, zipcode level education, and population density.
Overall survival was significantly longer in patients with esophageal cancers that underwent RAMIE in comparison to either MIE or OE in a 7-year NCDB cohort study.
与开放手术相比,微创食管癌切除术(RAMIE)与较低的发病率相关。机器人辅助微创食管癌切除术(RAMIE)与开放食管癌切除术(OE)和微创食管癌切除术(MIE)相比是否能带来更好的长期生存尚不清楚。
我们分析了 2010-2017 年国家癌症数据库(NCDB)中接受食管癌切除术的原发性食管癌患者的数据。排除了分期不明、远处转移或诊断为另一种癌症的患者。根据 RAMIE、MIE 和 OE 手术技术对患者进行分层。采用 Kaplan-Meier 方法和相关对数秩检验比较手术技术的未调整生存结果,这是我们的主要结果。采用多变量 Cox 比例风险回归模型确定对生存有独立影响的因素。
共纳入 5170 例接受食管癌切除术的患者;其中 428 例行 RAMIE,1417 例行 MIE,3325 例行 OE。总体中位生存时间为 42 个月。与 RAMIE 相比,行 MIE(危险比[HR] = 1.19;95%置信区间[CI]:> 1.00 至 1.41;P < 0.047)或 OE(HR = 1.22;95% CI:1.04 至 1.43;P < 0.017)的患者死亡风险增加。学术型与社区型项目设施类型与死亡风险降低相关(HR = 0.84;95% CI:0.76 至 0.93;P < 0.001)。一般来说,来自收入较低地区的男性、癌症晚期患者、接受新辅助化疗或放疗的患者死亡风险增加。与生存无关的因素包括种族和民族、Charlson-Devo 评分、健康保险类型、邮政编码水平教育和人口密度。
在 7 年 NCDB 队列研究中,与 MIE 或 OE 相比,接受 RAMIE 的食管癌患者的总体生存时间显著延长。